首页> 美国卫生研究院文献>Proteome Science >Clinical and Technical Phosphoproteomic Research
【2h】

Clinical and Technical Phosphoproteomic Research

机译:磷酸蛋白质组学的临床和技术研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An encouraging approach for the diagnosis and effective therapy of immunological pathologies, which would include cancer, is the identification of proteins and phosphorylated proteins. Disease proteomics, in particular, is a potentially useful method for this purpose. A key role is played by protein phosphorylation in the regulation of normal immunology disorders and targets for several new cancer drugs and drug candidates are cancer cells and protein kinases. Protein phosphorylation is a highly dynamic process. The functioning of new drugs is of major importance as is the selection of those patients who would respond best to a specific treatment regime. In all major aspects of cellular life signalling networks are key elements which play a major role in inter- and intracellular communications. They are involved in diverse processes such as cell-cycle progression, cellular metabolism, cell-cell communication and appropriate response to the cellular environment. A whole range of networks that are involved in the regulation of cell development, differentiation, proliferation, apoptosis, and immunologic responses is contained in the latter. It is so necessary to understand and monitor kinase signalling pathways in order to understand many immunology pathologies. Enrichment of phosphorylated proteins or peptides from tissue or bodily fluid samples is required. The application of technologies such as immunoproteomic techniques, phosphoenrichments and mass spectrometry (MS) is crucial for the identification and quantification of protein phosphorylation sites in order to advance in clinical research. Pharmacodynamic readouts of disease states and cellular drug responses in tumour samples will be provided as the field develops. We aim to detail the current and most useful techniques with research examples to isolate and carry out clinical phosphoproteomic studies which may be helpful for immunology and cancer research. Different phosphopeptide enrichment and quantitative techniques need to be combined to achieve good phosphopeptide recovery and good up- and-down phospho-regulation protein studies.
机译:诊断和有效治疗包括癌症在内的免疫病理学的一种令人鼓舞的方法是鉴定蛋白质和磷酸化蛋白质。尤其是,蛋白质组学是用于此目的的潜在有用方法。蛋白磷酸化在正常免疫学疾病的调节中起着关键作用,几种新型抗癌药物的靶点是癌细胞和蛋白激酶,而候选药物则是癌细胞。蛋白质磷酸化是一个高度动态的过程。新药的功能和选择对特定治疗方案最有效的患者一样,具有至关重要的作用。在细胞生命的所有主要方面,信令网络是在细胞间和细胞内通信中起主要作用的关键元素。它们参与各种过程,例如细胞周期进程,细胞代谢,细胞间通讯以及对细胞环境的适当反应。后者包含了涉及细胞发育,分化,增殖,凋亡和免疫应答调节的整个网络。因此,有必要了解和监测激酶信号传导途径,以了解许多免疫学病理学。需要从组织或体液样品中富集磷酸化的蛋白质或肽。免疫蛋白质组学技术,磷酸富集技术和质谱(MS)等技术的应用对于蛋白质磷酸化位点的鉴定和定量至关重要,以推动临床研究的发展。随着该领域的发展,将提供疾病状态和肿瘤样品中细胞药物反应的药效学读数。我们旨在通过研究实例详细介绍当前和最有用的技术,以分离和进行临床磷酸蛋白质组学研究,这可能对免疫学和癌症研究有所帮助。需要组合不同的磷酸肽富集和定量技术,以实现良好的磷酸肽回收率和良好的磷酸化调节蛋白的上下研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号